Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy

Fertil Steril. 2011 Feb;95(2):803.e1-2. doi: 10.1016/j.fertnstert.2010.07.1095. Epub 2010 Sep 16.

Abstract

Objective: To report the occurrence of Candida glabrata chorioamnionitis complicating an in vitro fertilization (IVF) pregnancy.

Design: Case report.

Setting: University hospital.

Patient(s): A 30-year-old woman, primagravida, with an IVF dichorionic-diamniotic pregnancy who presented at 15 weeks with vaginal bleeding.

Intervention(s): Before embryo transfer in next IVF cycle, vaginal culture from the patient revealed colonization with C. glabrata, which was treated with boric acid.

Main outcome measure(s): Subsequent pregnancy after eradication of fungal organisms.

Result(s): The patient's first pregnancy was treated with indomethacin and broad-spectrum antibiotics, but her membranes ruptured, and she delivered both twins at 16 weeks; the autopsy and pathology reports were consistent with C. glabrata chorioamnionitis. After boric acid treatment eradicated the organisms, two embryos were transferred in subsequent IVF treatment; the second pregnancy was uncomplicated, with dichorionic-diamniotic twins, delivered by cesarean section at 38 weeks.

Conclusion(s): Eradication of vaginal colonization with C. glabrata may prevent infection of the next IVF pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Boric Acids / therapeutic use
  • Candida glabrata* / physiology
  • Candidiasis / complications
  • Candidiasis / drug therapy*
  • Female
  • Fertilization in Vitro*
  • Fetal Death / prevention & control
  • Humans
  • Parity
  • Pregnancy
  • Pregnancy Complications, Infectious / diagnosis
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy, Multiple / physiology
  • Treatment Outcome
  • Twins

Substances

  • Antifungal Agents
  • Boric Acids
  • boric acid